---
figid: PMC5545683__ajcei0006-0027-f1
figtitle: Mechanisms of celebrex-mediated apoptosis
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC5545683
filename: ajcei0006-0027-f1.jpg
figlink: /pmc/articles/PMC5545683/figure/fig01/
number: F1
caption: Potential mechanisms of celebrex-mediated apoptosis. A. Either through direct
  cox-2 inhibition, or via induction of cyclins A, B and inhibition of cyclin-dependent
  kinase (CDK) activity, Celebrex inhibits tumor growth and induces cell cycle arrest.
  B. Cox-2 mediates the conversion of arachidonic acid to prostaglandin, which upregulates
  the expression of anti-apoptotic proteins Bcl-2, Bcl-xL, Mcl-1, survivin as well
  as increasing the activity of the PI3K/AKT anti-apoptotic signal transduction pathway.
  These events confer a growth advantage to the tumor cells. Celebrex, via cox-2 inhibition,
  interferes with the generation of prostaglandin resulting in down-regulation of
  anti-apoptotic genes and concurrent induction of pro-apoptotic Bax and Bak; facilitating
  the generation of a pro-apoptotic environment. C. In a cox-2-independent, apoptosome-dependent
  manner, Celebrex potentiates the formation of multi-protein complex apoptosome and
  caspase-9 processing, which in turn leads to processing and activation of executioner
  caspases-3, -6, -7, cleavage of death substrates and apoptosis.
papertitle: Combination of celecoxib (Celebrex®) and CD19 CAR-redirected CTL immunotherapy
  for the treatment of B-cell non-Hodgkin’s lymphomas.
reftext: Tam NM Dinh, et al. Am J Clin Exp Immunol. 2017;6(3):27-42.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.900734
figid_alias: PMC5545683__F1
figtype: Figure
redirect_from: /figures/PMC5545683__F1
ndex: afdf3e5d-df12-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5545683__ajcei0006-0027-f1.html
  '@type': Dataset
  description: Potential mechanisms of celebrex-mediated apoptosis. A. Either through
    direct cox-2 inhibition, or via induction of cyclins A, B and inhibition of cyclin-dependent
    kinase (CDK) activity, Celebrex inhibits tumor growth and induces cell cycle arrest.
    B. Cox-2 mediates the conversion of arachidonic acid to prostaglandin, which upregulates
    the expression of anti-apoptotic proteins Bcl-2, Bcl-xL, Mcl-1, survivin as well
    as increasing the activity of the PI3K/AKT anti-apoptotic signal transduction
    pathway. These events confer a growth advantage to the tumor cells. Celebrex,
    via cox-2 inhibition, interferes with the generation of prostaglandin resulting
    in down-regulation of anti-apoptotic genes and concurrent induction of pro-apoptotic
    Bax and Bak; facilitating the generation of a pro-apoptotic environment. C. In
    a cox-2-independent, apoptosome-dependent manner, Celebrex potentiates the formation
    of multi-protein complex apoptosome and caspase-9 processing, which in turn leads
    to processing and activation of executioner caspases-3, -6, -7, cleavage of death
    substrates and apoptosis.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CycA
  - CycB
  - Cdk4
  - COX2
  - Debcl
  - BC1
  - bc2
  - Akt
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - CycE
  - cyc
  - Fs(3)Bak
  - Dark
  - Dronc
  - CCNA1
  - CCNA2
  - CCNB1
  - CCNB2
  - CCNB3
  - CDKL1
  - CDKL2
  - CDKL3
  - CDKL4
  - CDKL5
  - CDK3
  - CDK4
  - CDK5
  - CDK6
  - CDK7
  - CDK8
  - CDK9
  - CDK10
  - CDK11A
  - CDK11B
  - CDK12
  - CDK13
  - CDK14
  - CDK15
  - CDK16
  - CDK17
  - CDK18
  - CDK19
  - CDK20
  - CDK1
  - CDK2
  - PTGS2
  - BCL2
  - CHMP2A
  - MCL1
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - BAK1
  - BAX
  - APAF1
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
---
